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Expression of Matrix Metalloproteinase-2
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Yon-Chi Cheng,2 Kai-Chen Hsu,2 Pse-Chou Cheng,8 Chin-Hai Lee,4 Young-Chau Liu3,9*
Background/Purpose: Betel quid extract (BQE) has been demonstrated to induce matrix metalloproteinase
(MMP)-2 expression. This study aimed to establish the possible mechanism involved in this event.
Methods: Western blotting, reverse-transcription polymerase chain reaction, and gelatin zymography were
used to study the expression level of MMP-2. LY294002, PD98059, U0126, N-acetyl-L-cysteine, SB203580,
SP600125, and Bay 11-7082 were used to pretreat OECM-1 cells before BQE treatment and MMP-2 detection.
Results: OECM-1 cells were subjected to short-term (10 minutes) or long-term (24 hours) BQE treatment
(designated as SBT and LBT, respectively), and we found that both treatments increased MMP-2 protein and ex-
tracellular signal-regulated kinase (ERK) phosphorylation levels in a concentration- and time-dependent man-
ner. LBT also increased MMP-2 mRNA level. LBT-induced MMP-2 secretion was not inhibited by PD98059 (up
to 50 μM) when ERK was effectively blocked, but was attenuated by LY294002 (0–10 μM) in a concentration-
dependent manner. This LBT effect was inhibited strongly by SB203580 (10 μM), SP600125 (10 μM), and
Bay 11-7082 (10 μM) and mildly by N-acetyl-L-cysteine (5 mM), but not by U0126 (10 μM).
Conclusion: Both SBT and LBT upregulate MMP-2 expression, and LBT-induced MMP-2 expression might be
mediated by phosphoinositide 3-kinase, p38 mitogen-activated protein kinase, c-Jun N-terminal kinase,
and nuclear factor-κB, and to a lesser extent, by reactive oxygen species, rather than by ERK.
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Degradation of type IV collagen, which is a major
component of basement membrane, is thought
to be a prerequisite for cancer cell invasion.1
Preferential degradation of type IV collagen by
matrix metalloproteinase (MMP)-2 has been
shown to play an important role in tumor inva-
sion and metastasis.2,3 Inhibition of its activity
blocks the migration of human endothelial and
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tumor cells, and prevents tumor growth and in-
vasion in animals.4 Recently, it has been shown
to play a more important role than MMP-9 in the
migration of astrocytes.5 This proteinase is now
considered to be a marker for the prediction of
oral and esophageal tumor malignancy.6–8
Betel quid (BQ) chewing is one of the most
popular oral habits worldwide. In Taiwan, BQ is
composed of an areca nut (AN) (Areca catechu
Linn.), slaked lime paste, and a piece of inflores-
cence of Piper betle (IPB) or P. betle leaf, and causes
a variety of oral diseases, including oral squamous
cell carcinoma (OSCC).9,10 The major AN alkaloids
arecoline and extract of AN inhibit the secretion
of MMP-2 into the culture medium of human buc-
cal mucosal fibroblasts, which is thought to be the
underlying mechanism of AN-induced oral sub-
mucous fibrosis (OSF).11 Reactive oxygen species
(ROS), which can be generated during BQ chewing,
are able to activate latent MMP-2 through the
phosphatidylinositol 3-kinase (PI3K) pathway
in a human fibrosarcoma cell line, and increase
MMP-2 expression in mouse vascular smooth
muscle cells.12,13 During BQ chewing, both posi-
tive and negative regulators of MMP-2 are pres-
ent, and investigation of the net effect of BQ on
MMP-2 expression might thus become of interest
and importance.
The expression of MMP-2 has been shown to be
driven by SP1, SP3, activator protein-1, and acti-
vator protein-2 transcription factors.14,15 Signals
that regulate these transcription factors, for exam-
ple, PI3K, might have the potential to turn on the
MMP-2 gene.16 Some recent studies have demon-
strated that Bcl-w, ionizing radiation, and nerve
growth factor induce MMP-2 expression and tu-
mor cell invasion through the Akt/PI3K signaling
pathway.17–19 Furthermore, the BQ components
have recently been shown to activate PI3K in dif-
ferent cell types.20–22 In addition to PI3K, mitogen-
activated protein kinase (MEK)/extracellular
signal-regulated kinase (ERK)-mediated pathway
has also been verified to activate SP1 transcription
factor and MMP-2 activity.23–25 Therefore, both
Akt/PI3K and MEK/ERK pathways are the potential
routes for BQ to regulate MMP-2 expression.
We have previously shown that 5 minutes
chewing of BQ and 1 minute treatment with BQ
extract (BQE) increases the proform MMP-2 pro-
tein level in the saliva, and the culture medium of
an OSCC cell line (OECM-1) and normal human
oral fibroblasts.26 However, whether MMP-2 ex-
pression is also upregulated after prolonged BQE
treatment remains unknown. To simulate the
fluctuating chewing period of BQ, we extended
BQE treatment of OECM-1 cells to 10 minutes
and 24 hours, and the expression of MMP-2 was
subsequently measured by western blotting and
reverse-transcription polymerase chain reaction
(RT-PCR). Inhibitors of PI3K (LY294002), ERK
(PD98059 and U0126), p38 mitogen-activated
protein kinase (MAPK) (SB203580), c-Jun 
N-terminal kinase (JNK) (SP600125), nuclear
factor (NF)-κB (Bay 11-7082), and the precursor
of glutathione (N-acetyl-L-cysteine; NAC) were
used to search for the possible mechanism of
BQE-regulated MMP-2 expression.
Materials and Methods
Preparation of BQE and chemical exposure
The preparation of BQE was performed as de-
scribed in our earlier studies.26,27 BQE (3.6–4.0 g
AN, 0.3–0.4 g inflorescence of P. betle, and
0.4–0.5 g lime) was place in a china bowl, and
ground in 5 mL phosphate-buffered saline (PBS)
with a china beetle thoroughly. The insoluble
materials were removed by 12,000g centrifugation
and the supernatant, after passing through the
200-μm filter, was used as the BQE (24.8 mg/mL).
The culture conditions of OECM-1 cells were ba-
sically the same as described earlier,26,27 except
that cells were treated with the indicated concen-
trations of BQE or arecoline (Sigma–Aldrich, 
St. Louis, MO, USA) for 10 minutes or 24 hours
under serum-free (SF) conditions. If cells were
subjected to 10 minutes treatment, the SF medium
was refreshed, and the cells were incubated for
the indicated periods of time. Furthermore, when
assessing the mechanism involved, the 24-hour
serum-starved OECM-1 cells were pretreated
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with the indicated concentrations of various in-
hibitors and NAC for 1–3 hours before BQE
(0.39 mg/mL) exposure for a further 24 hours.
Western blot analysis
The SF-conditioned medium and cell lysates after
BQE or arecoline treatment were collected and
subjected to western blot analysis as previously
described,27 except that the NC filter was im-
munoblotted with MMP-2 antibody (Chemicon,
Temecula, CA, USA) and subsequently with goat
anti-rabbit-IgG antibody coupled with horserad-
ish peroxidase (Chemicon). Signals were finally
revealed by Western Lightening Chemilumine-
scence Reagent (Perkin–Elmer, Boston, MA, USA).
For the loading control, the NC was either stained
with Ponceau S (Sigma Diagnostics, St. Louis,
MO, USA) before immunoblotting the separated
proteins in conditioned media, or re-probed with
β-actin antibody (Sigma Diagnostics) after immu-
noblotting lysate proteins.
Semi-quantitative RT-PCR
Preparation of total cellular RNA, conditions 
of RT-PCR, and primer sequences of glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) and
MMP-2 genes have been described in our previ-
ous work.26 In the present study, we also used the
b-actin gene (forward primer: 5’-GTGAAGGTCG-
GAGTCAACG-3’, reverse primer: 5’-CAATGCCA-
GCCCCAGCG-3’; product size = 895 bp) as the
control gene. Total RNA (1 μg) was reverse tran-
scribed into first-strand cDNA and 1/10 volume
of the cDNA product was subjected to PCR.
GAPDH and b-actin genes were amplified for 25
cycles, whereas MMP-2 gene was amplified for
27 cycles. The PCR products were then separated
by 1.5% agarose gel electrophoresis and stained
with 0.5 μg/mL ethidium bromide.
XTT assay
Cells were subjected to XTT assay to obtain refer-
ence cell numbers by using an XTT labeling
reagent and Cell Proliferation Kit II (Roche,
Indianapolis, IN, USA), according to the manu-
facturer’s instructions.
Zymography
Protocols for zymographic analysis were as de-
scribed in our previous study,26 except that 2 μg
protein from concentrated conditioned medium
was subjected to SDS-PAGE separation (with 10%
gel at 4°C). The current was set at 8 mA and 15 mA
when the dye front was localized within the stack-
ing and separation gel, respectively. The gel was
soaked in 100 mL 2.5% Triton-X 100 for 1 hour,
and transferred to 100 mL reaction buffer (50 mM
Tris–HCl, 200 mM NaCl, 5 mM CaCl2, 0.02%
Brij-35, pH7.4) for 16 hours at 37°C. Afterwards,
it was rinsed by 100 mL deionized water for 
5 minutes, stained by PhastGel Blue R (Amersham
Pharmacia Biotech, Uppsala, Sweden), and finally
destained in 100 mL solution of 10% acetic acid
and 30% methanol for 1–4 hours.
Statistical analysis
Two groups of data that were presented as mean ±
standard deviation were analyzed by Student’s 
t test. A value of p < 0.05 was regarded as statisti-
cally significant.
Results
Induction of MMP-2 expression by 
SBT and LBT
Our previous study has shown that 1 minute of
treatment with BQE enhances MMP-2 expression
in different oral cells.26 It is possible for oral cells
to be exposed to BQ constituents for > 1 minute
during BQ chewing, and the resulting impact on
MMP-2 expression remains unknown. Thus, we
analyzed the expression level of MMP-2 in the
lysates of OECM-1 cells collected at the indicated
period after 10 minutes SBT. Figure 1A reveals a
time-dependent increment of proform MMP-2
protein (72 kDa), which peaked at 8 hours (12-
fold increase in MMP-2/β-actin ratio compared
with control) and declined to a comparable level
to that of the control cells at 24 hours after 10
minutes SBT. Furthermore, the elevation of MMP-2
at 8 hours after SBT was BQE-concentration-
dependent (MMP-2/β-actin ratio was increased
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protein in the culture medium of OECM-1 cells,
as revealed by calculating the secreted MMP-2
protein/Ponceau S stained proteins ratio (Figure
2A). In contrast, 24 hours arecoline (40 μg/mL)
treatment decreased this ratio by about 10-fold
(Figure 2A); similar to buccal mucosal fibro-
blasts.11 The respective increase and decrease in
average secreted MMP-2 protein/Ponceau S stained
proteins ratios by LBT and arecoline treatment
were statistically significant from three indepen-
dent studies (Figure 2B; p < 0.05 in both cases).
To verify whether MMP-2 mRNA was also 
upregulated during LBT, total cellular RNA of
OECM-1 cells was isolated and subjected to
semi-quantitative RT-PCR analysis after 8 hours
and 24 hours BQE (0.39 mg/mL) treatment. The
results showed that MMP-2 mRNA level was sim-
ilar to the background level at 8 hours, but about
twofold (MMP-2/β-actin ratio) elevated after 24
hours of BQE treatment (LBT) (Figure 2C). The
increase in average MMP-2/β-actin ratio by LBT
was statistically significant from three independ-
ent studies (Figure 2D; p < 0.05).
Inhibition of LBT-induced MMP-2 secretion
by LY294002 rather than by PD98059
To assess whether LBT-mediated ERK phosphory-
lation plays a role in LBT-upregulated MMP-2 
secretion, cells were pretreated with various con-
centrations of PD98059 (0–50 μM) and the level
of secreted MMP-2 was measured. Figure 3A
shows that PD98059 (12.5 μM, 25 μM and 50 μM;
lanes 3–5) did not reduce LBT-induced (BQE =
0.39 mg/mL) elevation of secreted MMP-2 pro-
tein level (lane 2) under the conditions, without
attenuating cell viability as assessed by XTT assay
(plotted under lanes 1–5). To prove the inhibitory
potency against ERK1/2, PD98059 (25μM) used in
this study was further shown to inhibit effectively
the phosphorylation level of ERK (Figure 3B).
Several recent studies have demonstrated the
stimulation of MMP-2 expression by some distinct
signals through the PI3K pathway,18,19 therefore,
we were interested to analyze whether this kinase
plays a role in the LBT-induced increase in MMP-
2 secretion. Figure 4 reveals that the increase in
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Figure 1. Upregulation of matrix metalloproteinase
(MMP)-2 protein by short-term betel quid extract (BQE)
treatment (SBT). (A) Lysates of OECM-1 cells were col-
lected at the indicated period after 10 minutes SBT (BQE =
24.8mg/mL) and subjected to immunoblotting with MMP-2
and β-actin antibodies. (B) Lysates of OECM-1 cells were col-
lected after 10 minutes SBT with the indicated concentrations
of BQE for 8 hours and analyzed as in (A). (C) Average
MMP-2/β-actin ratios of untreated control and SBT cells
(BQE = 24.8 mg/mL) from three independent experiments
were presented as mean ± standard deviation; *p < 0.05.
2-fold, 7.3-fold and 14-fold by 6.2 mg/mL,
12.4 mg/mL and 24.8 mg/mL BQE treatment, 
respectively) (Figure 1B). The increase in average
MMP-2/β-actin ratio at 8 hours after 10 minutes
SBT (BQE = 24.8 mg/mL) was statistically sig-
nificant from three independent experiments
(Figure 1C; p < 0.05).
Oral tumor cells might be exposed to continu-
ous stimulation by BQ components in heavy
users, thus we further tested the regulation of
MMP-2 expression by LBT (BQE = 0.39 mg/mL) in
OECM-1 cells. Such treatment resulted in an ap-
proximately threefold increase in secreted MMP-2
Y.C. Liu, et al
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secreted MMP-2 protein level by LBT (BQE =
0.39 mg/mL) (lane 2) was decreased by LY294002
(5 μM and 10 μM) in a concentration-dependent
manner in both western blot and zymographic
analyses (lanes 3 and 4). None of these treatments
attenuated cell viability as illustrated by XTT assay
(plotted under each lane). The average MMP-2/
Ponceau S ratios of lane 3 and lane 4 from three
independent experiments were significantly lower
than that of lane 2 (plotted at the bottom of
Figure 4) (p < 0.05 and p < 0.01, respectively).
Strong inhibition of LBT-induced MMP-2
secretion by SB203580, SP600125 and 
Bay 11-7082
It has recently been shown that the connective
tissue growth factor (CTGF) can be induced by
Figure 2. Upregulation of matrix metalloproteinase
(MMP)-2 protein and mRNA by long-term betel quid extract
(BQE) treatment (LBT). (A) Conditioned media of OECM-1
cells treated with LBT (BQE = 0.39 mg/mL) and arecoline
(40μg/mL) for 24 hours were collected and immunoblotted
with MMP-2 and β-actin antibodies. Ponceau S staining was
used as the protein loading control. MMP-2/Ponceau S ratio
is listed under each lane. (B) Average MMP-2/Ponceau S
ratios from three independent experiments of (A) are pre-
sented as mean ± standard deviation. (C) Total cellular RNA
from OECM-1 cells treated with BQE (0.39 mg/mL) for 
0, 8 and 24 hours were isolated and subjected to semi-
quantitative reverse-transcription-polymerase chain reaction.
MMP-2/β-actin ratio is listed under each lane. (D) Average
MMP-2/β-actin ratios from three independent experiments
of (C) are presented as mean± standard deviation; *p<0.05.
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Figure 3. Effect of PD98059 on long-term betel quid extract
(BQE) treatment (LBT)-induced matrix metalloproteinase
(MMP)-2 secretion and extracellular signal-regulated kinase
(ERK) phosphorylation. (A) Conditioned media of OECM-1
cells treated with or without PD98059 (0–50 μM) for 3
hours and subsequently with LBT (BQE=0.39 mg/mL) were
subjected to MMP-2 immunoblotting. MMP-2/Ponceau S
ratio is listed under each lane. Cell viability after each treat-
ment was analyzed by XTT assay and the result is plotted
under each lane. (B) Lysates of OECM-1 cells treated with
or without PD98059 (25 μM) and subsequently with LBT
were subjected to immunoblotting with phosphorylated
ERK (pERK), total ERK (tERK), and b-actin antibodies.
pERK/tERK ratio is listed under each lane.
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arecoline through ROS, NF-κB, JNK and P38
MAPK pathways.28 We therefore further tested
whether LBT-induced MMP-2 secretion was af-
fected by pretreating cells with 5 mM of antioxi-
dant NAC, and 10 μM of NF-κB inhibitor Bay
11-7082, JNK inhibitor SP600125, or p38 MAPK 
inhibitor SB203580 (another MEK/ERK inhibitor
U0126 was also included) for 1 hour. SB203580,
SP600125, and Bay 11-7082 strongly inhibited
LBT-induced MMP-2 secretion, whereas NAC and
U0126 respectively exhibited mild and no in-
hibitory effects (Figure 5A). No significant cyto-
toxicity of these treatments was detected by XTT
assay (plotted under each lane, Figure 5B). The
average MMP-2/Ponceau S ratio of SB203580,
SP600125 and Bay 11-7082 treatments (from three
independent experiments) was significantly lower
than that with LBT alone (Figure 5C) (p < 0.01,
p < 0.05 and p < 0.01, respectively).
Discussion
We demonstrated the stimulation of MMP-2 ex-
pression by different concentrations and durations
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Figure 4. Effect of LY294002 on long-term betel quid 
extract treatment (LBT)-induced matrix metalloproteinase
(MMP)-2 secretion. (A) Conditioned media of OECM-1 cells
treated with or without LY294002 (0–10 μM) for 3 hours
were collected after LBT and subjected to immunoblotting
with MMP-2 antibody or zymographic analysis. The MMP-2/
Ponceau S ratio of each treatment is listed under each lane.
The results of XTT assay and the average MMP-2/Ponceau
S ratio from three independent experiments (mean ±
standard deviation) are plotted under each lane. *p < 0.05,
**p < 0.01. Figure 5. Effect of N-acetyl-L-cysteine (NAC), U0126,
SB203580, SP600125, and Bay 11-7082 on long-term betel
quid extract treatment (LBT)-induced matrix metallopro-
teinase (MMP)-2 secretion. (A) Conditioned media of
OECM-1 cells treated with 10 μM U0126, SB203580,
SP600125 or Bay 11-7082, or 5 mM NAC for 1 hour were
collected after LBT and subjected to immunoblotting with
MMP-2 antibody. The results of XTT assay and the average
MMP-2/Ponceau S ratio from three independent experi-
ments (mean ± standard deviation) are plotted under each
lane. *p < 0.05, **p < 0.01.
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of BQE treatment. The BQE-stimulated MMP-2
expression might be independent of ERK, because
it was not inhibited by either PD98059 or U0126.
On the other hand, our preliminary pharmaco-
logical results suggest that p38 MAPK, JNK, NF-κB,
and ROS are involved in this event.
Cellular responses to some specific BQ com-
ponents have commonly been regarded as the
mechanisms of BQ-mediated effects. However,
our recent studies have revealed that distinct cel-
lular responses might occur after stimulation by
a specific BQ ingredient and the crude extract of
AN or BQ. For example, both AN extract (ANE)
and arecoline have been demonstrated to inhibit
the expression of MMP-2,11 but BQE has been
shown to enhance it.26 Furthermore, arecoline and
hydroxychavicol have been verified to induce
apoptosis,29,30 but we have found that ANE trig-
gers autophagy.31,32 Our unpublished data also
indicate the induction of autophagy by BQE.
Thus, although ANE and arecoline have been
shown to stimulate ERK phosphorylation,33,34 it
is possible for BQE to exert different regulation
on ERK. We tested whether SBT and LBT were
able to stimulate ERK phosphorylation, and the
results showed that SBT and LBT both stimulated
ERK phosphorylation in a dose- and/or time-
dependent manner (Supplemental Figures 1A–C)
under non-cytotoxic conditions (Supplemental
Figures 1D and 1E). Therefore, we could have
provided the first evidence for the stimulation of
ERK by BQE.
Previously we have shown that MMP-2 expres-
sion is stimulated for 2–4 hours after 1 minute
treatment with BQE (2.25 mg/mL), in OECM-1
and normal oral fibroblasts.26 In the present study,
MMP-2 expression was further demonstrated to
be upregulated by 10 minutes SBT and 24 hours
LBT (Figures 1 and 2). Thus, oral tumor cells might
have the potential to express more MMP-2 pro-
teins during (or after) the usage of BQ for various
durations. The regulation point of SBT-induced
accumulation of MMP-2 protein is not clear;
however, LBT-upregulated MMP-2 secretion was
shown to be at the transcriptional level (Figures 2C
and 2D).
We have also previously shown that MMP-2
mRNA was expressed in 26 of 28 OSCC specimens
from long-term BQ users.26 Further examination
of MMP-2 mRNA in another 66 OSCC specimens
from BQ users by RT-PCR demonstrated that 
65 specimens were MMP-2 positive (some of
these RT-PCR results are shown in Supplemental
Figure 2A). Thus, in 94 OSCCs from BQ users, the
expression rate of MMP-2 was 96.8% (91/94).
These results confirm our previous speculation
that BQ consumption does not inhibit the expres-
sion of this proteinase. Furthermore, the adjacent
tissues of 37 of the 66 OSCCs were available and,
together with their tumor counterparts, subjected
to the measurement of MMP-2 mRNA level by
semi-quantitative RT-PCR. We found that in 37
pairs of OSCCs and their normal neighboring
tissues (T1N1-T37N37), MMP-2 mRNA was pref-
erentially expressed in 30 OSCCs, and the average
MMP-2/GAPDH ratio of these 37 OSCCs (Tav)
was significantly higher than that of their neigh-
boring tissues (Nav) (Supplemental Figure 2B;
p < 0.05). In conclusion, our present and previous
studies demonstrate that, in BQ users, MMP-2 is
commonly expressed in OSCCs specimens and
upregulated in most OSCCs compared with their
neighboring tissues. This is despite the fact that
MMP-2 expression was inhibited by arecoline in
OECM-1 cells (Figure 2A), and in normal buccal
mucosal fibroblasts in a previous study.11
MMP-2 is induced in OECM-1 cells and nor-
mal oral fibroblasts by BQE treatment,26 there-
fore, it is reasonable to speculate that MMP-2
expression might be upregulated in normal and
malignant oral cells during BQ chewing, which
in turn promotes tumor invasion/migration. This
speculation is partially supported by two pieces
of evidence. One is our previous observation 
that MMP-2 protein level in the saliva was evi-
dently elevated at 2 hours after BQ chewing.26
The other is from the recent study of Lu et al,
who have shown that MMP-2 activation was
identified in the conditioned medium of ANE-
treated senescent fibroblasts. Lu et al also showed
that polymorphonuclear leukocytes treated with
the supernatant of ANE-treated cells exhibited 
Betel-quid-extract-induced MMP-2 expression
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a significant increase in invasiveness, which was
abrogated by MMP-2 blocker and MMP-2 nulli-
fying antibody.35
LBT-upregulated MMP-2 secretion was not 
attenuated under the conditions that ERK was 
effectively blocked by PD98059 (Figure 3B) and
U0126 (Figure 5), which indicates the involve-
ment of some other pathways. Some independent
studies have collectively suggested the participa-
tion of the PI3K pathway in the BQE-regulated
MMP-2 expression. First of all, BQE has been
shown to induce the generation of ROS,36,37 and
ROS can activate MMP-2 and increase MMP-2
expression.12 Moreover, the PI3K pathway has
been demonstrated to control the generation of
ROS38,39 and the expression of MMP-2.19 There-
fore, BQE might induce ROS generation through
PI3K, and then upregulate MMP-2 expression.
This speculation is supported in part by our pre-
liminary results that LY294002 dose-dependently
inhibited the LBT-mediated elevation of MMP-2
secretion (Figure 4).
On the other hand, ROS are known to stim-
ulate the PI3K/Akt pathway,40 as well as the acti-
vation and phosphorylation of stress kinases
(including JNK and p38) and redox-sensitive
transcription factors such as NF-κB and AP-1.41 It
might therefore be possible for BQE to upregu-
late MMP-2 expression by activating PI3K, JNK,
p38 and NF-κB through ROS; that is, ROS could
be the upstream regulator of PI3K, JNK, p38 and
NF-κB. Further studies are required to delineate
their sequence along the BQE-stimulated signal-
ing pathway.
Deng et al demonstrated that arecoline-
induced CTGF synthesis is sensitive to NAC, Bay
11-7082, SP600125 and SB203580, but not to
PD98059;28 a regulation pattern that is similar to
LBT-induced MMP-2 expression. Therefore, one
might expect that BQE would have the potential
to upregulate MMP-2 through CTGF. However,
Yang et al showed that CTGF increases MMP-2
expression in a PD98059-sensitive manner.42
Therefore, there could be other factors other 
than CTGF that mediate BQE-induced MMP-2
expression.
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